0.685
price down icon15.94%   -0.1299
after-market After Hours: .69 0.005 +0.73%
loading
Aclarion Inc stock is traded at $0.685, with a volume of 3.50M. It is down -15.94% in the last 24 hours and down -85.52% over the past month. Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$0.8149
Open:
$0.7471
24h Volume:
3.50M
Relative Volume:
0.10
Market Cap:
$695.88K
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.0754
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
-57.19%
1M Performance:
-85.52%
6M Performance:
+260.53%
1Y Performance:
+90.81%
1-Day Range:
Value
$0.6466
$0.77
1-Week Range:
Value
$0.6466
$1.79
52-Week Range:
Value
$0.0275
$20.84

Aclarion Inc Stock (ACON) Company Profile

Name
Name
Aclarion Inc
Name
Phone
833 275 2266
Name
Address
8181 ARISTA PLACE, BROOMFIELD
Name
Employee
6
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ACON's Discussions on Twitter

Compare ACON with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
ACON
Aclarion Inc
0.685 695.88K 49,300 -6.27M -5.38M -9.09
Health Information Services icon
VEEV
Veeva Systems Inc
227.80 36.98B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
SOLV
Solventum Corp
72.30 12.51B 8.26B 66.00M 1.17B 0.3682
Health Information Services icon
DOCS
Doximity Inc
60.80 11.41B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
HQY
Healthequity Inc
93.97 8.14B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
TEM
Tempus Ai Inc
42.16 7.26B 640.44M -743.28M -206.93M -11.29

Aclarion Inc Stock (ACON) Latest News

pulisher
Mar 13, 2025

Aclarion provides shareholder update, to file 10K by March-end -March 13, 2025 at 11:00 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Aclarion, Inc. secures compliance with Nasdaq equity rule - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Aclarion Provides Shareholder Update - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Aclarion Sets Major Corporate Update: 8-K Filed, 10-K Coming for AI Healthcare Pioneer - StockTitan

Mar 13, 2025
pulisher
Mar 11, 2025

Aclarion announces expansion plans with RadNet affiliates in NY, NJ - MSN

Mar 11, 2025
pulisher
Mar 07, 2025

Aclarion, a company using remote MRIs to assess back pain, expands in partnership with RadNet - Radiology Business

Mar 07, 2025
pulisher
Mar 06, 2025

United States shares lower at close of trade; Dow Jones Industrial Average down 0.99% - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.99% - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Aclarion expands Nociscan access in New York, New Jersey - AuntMinnie

Mar 06, 2025
pulisher
Mar 06, 2025

Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey - The Globe and Mail

Mar 06, 2025
pulisher
Mar 06, 2025

Aclarion to Expand Nociscan Access in New York, New Jersey -March 06, 2025 at 12:00 pm EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Aclarion Announces Expansion Plans With RadNet Affiliates In New York And New Jersey - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Aclarion stock hits 52-week low at $2.26 amid sharp annual decline - Investing.com Australia

Mar 06, 2025
pulisher
Mar 06, 2025

Aclarion expands Nociscan sites in New York, New Jersey - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Aclarion shareholders approve stock issuance and charter amendment - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Dow Tumbles 1%; US Initial Jobless Claims Decline - Benzinga

Mar 06, 2025
pulisher
Mar 06, 2025

Aclarion expands Nociscan sites in New York, New Jersey By Investing.com - Investing.com UK

Mar 06, 2025
pulisher
Mar 06, 2025

Aclarion, Inc. Announces Expansion of Nociscan Access in New York and New Jersey to Address Chronic Low Back Pain - Nasdaq

Mar 06, 2025
pulisher
Mar 06, 2025

Can This 97% Effective Spine Technology Transform RadNet's 112 Medical Centers? - StockTitan

Mar 06, 2025
pulisher
Mar 06, 2025

Aclarion shareholders approve stock issuance and charter amendment By Investing.com - Investing.com UK

Mar 06, 2025
pulisher
Mar 05, 2025

Is Aclarion's Tie-Up With Scripps Health A Lasting Catalyst? Most Retail Traders Think It's A 'Game-Changer' - Asianet Newsable

Mar 05, 2025
pulisher
Mar 04, 2025

The amazing story behind Aclarion’s 126% stock surge and future prospects - Dataconomy

Mar 04, 2025
pulisher
Mar 03, 2025

Aclarion Partners with Scripps Health to Bring Chronic Low Back Pain Solution to Southern California - HIT Consultant

Mar 03, 2025
pulisher
Mar 03, 2025

Aclarion Expands Nociscan to Scripps Health, Advancing Chronic Low Back Pain Diagnostics in Southern California - Apna Kal

Mar 03, 2025
pulisher
Mar 03, 2025

Why Aclarion (ACON) Shares Are Skyrocketing - Benzinga

Mar 03, 2025
pulisher
Mar 03, 2025

Aclarion (NASDAQ: ACON) Soars on Scripps Health Partnership, Expanding Nociscan's Reach - Apna Kal

Mar 03, 2025
pulisher
Mar 03, 2025

Aclarion to Provide Imaging Technology to Scripps Health in California; Shares Jump -March 03, 2025 at 09:33 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday? - Benzinga India

Mar 03, 2025
pulisher
Mar 03, 2025

Aclarion (ACON) Shares Surge In Pre-Hour Trading Amid Key Healthcare Deal - Stocks Telegraph

Mar 03, 2025
pulisher
Mar 03, 2025

Aclarion rises on commercial agreement with Scripps Health - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

Aclarion Expands Access to Nociscan Technology Through Agreement with Scripps Health in San Diego Area - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Aclarion Announces First Commercial Agreement with Scripps Health - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

How Aclarion's New Scripps Health Deal Could Transform Chronic Back Pain Diagnosis - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

LGVN To Complete ELPIS II Enrollment By Q2, Time To Keep An Eye On NXGL, What's The Buzz At ACON? - RTTNews

Mar 03, 2025
pulisher
Mar 01, 2025

Aclarion, Inc. (NASDAQ:ACON) Short Interest Up 1,730.4% in February - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Aclarion, Inc. Adjourns Special Meeting for More Votes - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders - The Manila Times

Feb 28, 2025
pulisher
Feb 28, 2025

Aclarion Postpones Critical Stockholder VoteWill March 5 Meeting Secure Enough Support? - StockTitan

Feb 28, 2025
pulisher
Feb 25, 2025

Aclarion stock hits 52-week low at $3.82 amid sharp annual decline - Investing.com Canada

Feb 25, 2025
pulisher
Feb 25, 2025

Aclarion stock hits 52-week low at $3.82 amid sharp annual decline By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 24, 2025

(ACON) Technical Data - Stock Traders Daily

Feb 24, 2025
pulisher
Feb 20, 2025

Aclarion, Inc. (ACON) to Showcase NOCISCAN’s Impact on Spine Surgery at 2025 Spine Summit - Yahoo Finance

Feb 20, 2025
pulisher
Feb 20, 2025

Top 8 Must-See AI News Updates Investors Probably Missed - Insider Monkey

Feb 20, 2025
pulisher
Feb 20, 2025

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit - EIN News

Feb 20, 2025
pulisher
Feb 20, 2025

Aclarion Showcases NOCISCAN's Innovative Role in Chronic Low Back Pain Management at 2025 Spine Summit, Led by Dr. Nicholas Theodore - Nasdaq

Feb 20, 2025
pulisher
Feb 20, 2025

Can This AI-Powered Technology Finally Solve the $300B Chronic Back Pain Crisis? - StockTitan

Feb 20, 2025
pulisher
Feb 16, 2025

Aclarion secures patent for infection, pain biomarker detection - MSN

Feb 16, 2025
pulisher
Feb 13, 2025

Short Interest in Aclarion, Inc. (NASDAQ:ACON) Decreases By 99.8% - Defense World

Feb 13, 2025
pulisher
Feb 12, 2025

Aclarion receives U.S. patent on expanded applications of MRS data processing - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Aclarion stock hits 52-week low at $4.41 amid steep annual decline - MSN

Feb 12, 2025

Aclarion Inc Stock (ACON) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$10.43
price down icon 5.27%
$4.47
price down icon 4.08%
$23.38
price down icon 2.66%
$16.96
price down icon 4.50%
health_information_services WAY
$35.27
price down icon 4.37%
health_information_services TEM
$42.16
price down icon 7.33%
Cap:     |  Volume (24h):